Mortara Instrument to exhibit at CSRC; QT Assessment Early Clinical Development February 2012

January 26, 2012

MILWAUKEE, WI—January 26, 2012—Mortara Instrument will exhibit its complete product portfolio of diagnostic ECG and cardiology monitoring products at CSRC; QT Assessment Early Clinical Development hosted at the FDA White Oak Facility in Silver Spring, Maryland.  Visit https://www.cardiac-safety.org/think-tanks/november-2011/thinktank-meeting-on-qt-assessment-in-early-clinical-development for more information.

Learn more about Mortara’s go wireless™ technology when you visit us.

About Mortara Instrument

Mortara Instrument, Inc. was founded nearly 30 years ago and today is a recognized technology leader in the world of ECG.  Mortara’s global headquarters is located in Milwaukee, Wisconsin with operations in Australia, Germany, Italy, the Netherlands, and the United Kingdom.  Mortara is distinguished in the field of non-invasive cardiology for innovations that are the core of the company's complete line of ECG products including electrocardiographs, stress exercise systems, Holter systems, data warehousing solutions, and cardiology monitoring systems.  The company manufactures and distributes its ECG devices and related technologies worldwide.  Mortara’s market leadership is a result of its substantial investment in R & D which has fueled the introduction of many new Mortara products uniquely positioned to benefit customers in their everyday use of diagnostic ECG devices.  To learn more about Mortara Instrument and its expanding product portfolio visit www.mortara.com.